Thus we re-classified the subjects in our study using the spirometry reference prediction equations from the NHANES III (16) and NSE (17) studies to confirm that the subjects defined with COPD by the GOLD guidelines did have a spirometry FEV1/FVC lower that the lower limit of normal FEV1/FVC (Table 2). This evidence concerns the gene ENO2 and chronic obstructive pulmonary disease.